In accordance with these reports, we found that GMSCs, which highly expressed CD39 and CD73, could inhibit T effector cells differentiation in vitro and this function was significantly abrogated by CD39 or CD73 inhibitor treatment, which could also be a mechanism of the in vivo suppression of GMSCs on T1DM. The gene discussed is NT5E; the disease is type 1 diabetes mellitus.